Probiotics and Prebiotics as Bioactive Components in Dairy Products

Bioactive Components in Milk and Dairy Products

Volumn , Issue , 2009, Pages 287-310

  Jin Baek, Young ^a   Lee, Byong H ^b  

^a Korea Yakult Company   (South Korea)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Beneficial effects of probiotics; Beneficial effects of yogurt; Inflammatory bowel disease (IBD) showing improvement with probiotics; Intestinal flora ecology; Lactic acid bacteria (LAB) and fermented milk; Lactobacillus Acidophilus, Lb. acidophilus Gram positive, catalase negative, rod shaped bacterium; Molecular tools in tracing GI microbes and starters; Probiotic strains; Probiotics and prebiotics as bioactive components in dairy products; Urogenital and vaginal health

Indexed keywords

EID: 84889623996     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813821504.ch12     Document Type: Chapter

References (135)

1. Aas J., Paster B., Stokes L., Olsen I., and Dewhirst F. 2005. Defining the normal bacterial flora of the oral cavity. Journal of Clinical Microbiology 43: 5721-5732.
2. Abrahamsson T.R., Jakobsson T., Bottcher M.F., Fredrikson M., Jenmalm M.C., Bjorksten B., and Oldaeus G. 2007. Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology 119: 1174-1180.
3. Adams M.R., and Marteau P. 1995. On the safety of lactic acid bacteria from food. International Journal of Food Microbiology 27: 263-264.
4. Ahn J.E., Park S.Y., and Lee B.H. 2007. Optimization of whey-based medium for growth and ACE-inhibitory activity of Lactobacillus brevis. Journal of Dairy Science and Technology 25: 1-7.
5. Aihara K., Kajimoto O., Hirata H., Takahashi R., and Nakamura Y. 2005. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of the American College of Nutrition 24: 257-265.
6. Amor K.B., Vaughan E.E., and de Vos W.M. 2007. Advanced molecular tools for the identification of lactic acid bacteria. Journal of Nutrition 137: 741S-747S.
7. Anderson J.W., and Gilliland S.E. 1999. Effect of fermented milk (yoghurt containing Lactobacillus acidophilus Li on serum cholesterol in hypercholesterolemic humans. Journal of American College of Nutrition 18: 43-50.
8. Ballongue J. 1993. Bifidobacteria and probiotic action. In: Lactic Acid Bacteria, Seppo Salminen and Atte von Wright (eds.), pp. 357-428. Marcel Dekker, Inc., New York.
9. Ballongue J., Schumann C., and Quignon P. 1997. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scandinavian Journal of Gastroenterology Suppl 222: 41-44.
10. Berrada N., Lemeland J.F., Laroche R., Thouvenot P., and Piaia M. 1991. Bifidobacterium from fermented milks: survival during gastric transit. Journal of Dairy Science 74: 409-413.
11. Bhatia S.J., Kochar N., Abraham P., Nair N.G., and Mehta A.P. 1989. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. Journal of Clinical Microbiology 27: 2328-2330.
12. Biavati B., and Mattarelli P. 2001. The family Bifi-dobacteriaceae. In: The Prokaryotes, M. Dworkin, S. Falkow, E. Rosenberg, K.H. Schleifer, and E. Stackebrandt (eds.), pp. 1-70. Springer, New York.
13. Blanco M., Sotelo C.G., Chapela M.J., and Pérez-Martín R.I. 2007. Towards sustainable and effi-cient use of fishery resources: present and future trends. Trends in Food Science and Technology 18: 29-36.
14. Bomba A., Nemcova R., Mudronova D., and Guba P. 2002. The possibilities of potentiating the effi-cacy of probiotics. Trends in Food Science and Technology 13: 121-126.
15. Bonten M.J.M., Willems R., and Weinstein R.A. 2001. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infectious Diseases 1: 314-325.
16. Boyle R.J., Robins-Browne R.M., and Tang M.L. 2006. Probiotic use in clinical practice: what are the risks? American Journal of Clinical Nutrition 83: 1256-1264.
17. Broekaert I., and Walker W. 2006. Probiotics and chronic disease. Journal of Clinical Gastroenterology 40: 270-274.
18. Broekaert I., and Walker W. 2007. Probiotics as flourishing benefactors for human body. Nutrition Today 41: 6-14.
19. Burton J.P., Wescombe P.A., Moore C.J., Chilcott C.N., and Tagg J.R. 2006. Safety Assessment of the Oral Cavity Probiotic Streptococcus salivarius K12. Applied Environmental Microbiology 72: 3050-3053.
20. Cabana M.D., Shane A.L., Chao C., and Oliva-Hemker M. 2006. Probiotics in primary care pediatrics. Clinical Pediatrics 45: 405-410.
21. Collins J.K., Thornton G., and Sullivan G.O. 1998. Selection of probiotics strains for human applications. International Dairy Journal 8: 487-490.
22. Commane D., Hughes R., Shortt C., and Rowland I. 2005. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutation Research 591: 276-289.
23. Corrier D.E., Hinton A., Jr., Ziprin R.L., and DeLoach J.R. 1990. Effect of dietary lactose on Salmonella colonization of market-age broiler chickens. Avian Diseases 34: 668-676.
24. Crittenden R.G., and Playne M.J. 1996. Production, properties, and applications of food-grade oligosaccharides. Trends in Food Science and Technology 7: 353-361.
25. Cross M.L., Stevenson L.M., and Gill H.S. 2001. Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria? International Immunopharmacology 1: 891-901.
26. da Cruz A.G., Faria J.D.F., and Van Dender A.G.F. 2007. Packaging system and probiotic dairy foods. Food Research International 40: 951-956.
27. De Smet I., Boever P.D., and Verstraete W. 1998. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. British Journal of Nutrition 79: 185-194.
28. Devine D.A. 2007. Periodontist: Prospects for the development of novel therapies using probiotics, prebiotics and derivatives of innate defense molecules. pp. 42-75. The 15th International Symposium on Lactic Acid Bacteria in Seoul, Korea. Lactic acid bacteria and oral health. (August 22, 2007).
29. Donkor O.N., Hernriksson A., Singh T.K., Vasiljevic T., and Sha N.P. 2007. ACE-inhibitory activity of probiotic yogurt. International Dairy Journal 17: 1321-1331.
30. Donohue D.C., and Salminen S.J. 1996. Safety of probiotic bacteria. Asia Pacific Journal of Clinical Nutrition 5: 25-28.
31. Edens F.W., Parkhurst C.R., Casa l.A., and Dorbrogosz W.J. 1997. Principles of ex ovo competitive exclusion and in ovo administration of Lactobacillus reutri. Poultry Science 76: 179-196.
32. Falagas M.E., Betsi G.I., and Athanasiou S. 2006. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy 58: 266-272.
33. FAO/WHO. 2002. Guidelines for the evaluation of probiotics in food. http://www.who.intlfoodsafety/fs_management/en/probioticguidelines.pdf (Accessed November 24, 2007).
34. Fitzgerald R.J., Murray B.A., and Walsh D.J. 2004. Hypotensive peptides from milk proteins. American Society of Nutrition Science 134: 980s-988s.
35. Fuller R. 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-78.
36. Fuller R. 1991. Probiotics in human medicine. Gut 32: 439-442.
37. Fuller R. 1992. History and development of probiotics. In: Probiotics: The Scientific Basis, Roy Fuller (ed.), pp. 1-8. Chapman & Hall, London, UK.
38. Geier M.S., Butler R.N., and Howarth G.S. 2006. Probiotics, Prebiotics and Symbiotics: A role in chemoprevention for colorectal. Cancer Biological Therapy 5: 1265-1269.
39. GhisolfiJ., Roberfroid M., Rigo J., Moro G., and Polanco I. 2002. Infant formula supplemented with probiotics or prebiotics. Journal of Pediatric Gastroenterology Nutrition 35: 467-469.
40. Gibson G.R., and Collins D. 1997. Concept of balanced colonic microbiota, prebiotics and symbiotics. Probiotic symposium in Beijing 19: 1-19.
41. Gibson G.R., and Roberfroid M.B. 1995. Dietary modulation of the human colonic microbiota-introducing the concept of prebiotics. Journal of Nutrition 125: 1401-1412.
42. Gilliland S.E. 1979. Beneficial interrelationships between certain microorganisms and humans: Candidate microorganisms for use as dietary adjuncts. Journal of Food protection 42: 164-167.
43. Gilliland S.E. 1996. Special Additional Cultures Dairy Starter Cultures, T.M. Cogan, and J-P. Accolas (eds.), pp. 233-248. VCH publishers, Inc., New York.
44. Guandalini S., Pensabene L., Zikri M.A., Dias J.A., Casali L.G., Hoekstra H., Kolacek S., Massar K., Micetic-Turk D., Papadopoulou A., de Sousa J.S., Sandhu B., Szajewska H., and Weizman Z. 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatric Gastroenterology Nutrition 30: 54-60.
45. Guarner F. 2007. Role of intestinal flora in health and disease. Nutricion Hospitalaria 22: 14-19.
46. Guarner F., Perdigon G., Corthier G., Salminen S., Kolerzko B., and Morelli L. 2005. Should Yoghurt cultures be considered probiotic? British Journal of Nutrition 93: 783-786.
47. Harsey J., and Pharm M.S. 2008. Current and future treatment modalities for Clostridium difficile-associated disease. American Journal of Health-System Pharmacy 65: 705-715.
48. Hatakka K., Ahola A.J., Yli-Knuuttila H., Richardson M., Poussa H., Meurman J.H., and Korpela R. 2007. Probiotics reduce the prevalence of oral Candida in the elderly: A randomized controlled trial. Journal of Dental Research 86: 125-130.
49. Havenaar R., and Huis in't Veld J.H.J. 1992. Probiotic: A general review. The Lactic acid Bacteria. VOL 1, Brian J.B. Wood (ed.), pp. 151-170. Elsevier Applied Science, London and New York.
50. He F., Priebe M.G., Zhong Y., Huang C., Harmsen H.J.M., Raangs G.C., Antoine J.-M., Welling G. W., and Vonk R.J. 2008. Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. Journal of Applied Microbiology 104: 595-604.
51. Holm A., and Poulsen H.D. 1996. Zinc oxide in treating E. coli diarrhea in pigs after weaning. Comparative Continuous Education Practical Veterinary 18: 26-30.
52. Holzapfel W.H., Haberer P., Snel J., Schillinger U., and Huis In't Veld J.H.J. 1998. Overview of gut flora and probiotics. International Journal of Food Microbiology 41: 85-101.
53. Hosoda M., Hashimoto H., He F., Morita H., and Hosono A. 1996. Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine. Journal Dairy Science 79: 745-749.
54. Huang M.K., Choi Y.J., Houde R., Lee J.W., Lee B.H., and Zhao X. 2004. Effects of Lactobacilli and an acidophilic fungus on the production performance and immune responses in broiler chickens. Poultry Science 83: 788-795.
55. Ibrahim S.A., and O'Sullivan D.J. 2000. Use of chemical mutagenesis for the isolation of food grade beta-galactosidase overproducing mutants of bifidobacteria, lactobacilli and Streptococcus thermophilus. Journal Dairy Science 83: 923-930.
56. Joint Food and Agriculture Organization/World Health Organization Working Group. 2002. Guidelines for the evaluation of probiotics in food. http://www.fao.org/es/esn/food/
57. Kabir A.M.A., Aiba Y., Takagi A., Kamiya S., Miwa T., and Koga Y. 1997. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41: 49-55.
58. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., and lsolauri E. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
59. Kang M.S., Kim B.G., Chung J., Lee H.C., and Oh J.S. 2006. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. Journal of Clinical Periodontology 33: 226-232.
60. Kim G.B., Miyamoto C.M., Meighen E.A., and Lee B.H. 2004. Cloning and characterization of the bile salt hydrolase gene (bsh) from Bifidobacterium bifidum strains. Applied Environmental Microbiology 70: 5603-5612.
61. Kim H.S., and Gilliland S.E. 1983. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. Journal Dairy Science 66: 956-966.
62. Koebnick C., Wagner I., Leitzmann P., Stem U., and Zunft H.J. 2003. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Canadian Journal of Gastroenterology 17: 655-659.
63. Krasse P., Carlsson B., Dahl C., Paulsson A., Nilsson A., and Sinkiewicz G. 2006. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swedish Dental Journal 30: 55-60.
64. Kroger M., Kurmann J.A., and Rasic J.L. 1989. Fermented milk-past and present. Food Technology 43: 92-99.
65. Kruis W., Fric P., Pokrotnieks J., Lukas M., Fixa B., Kascak M., Kamm M.A., Weismueller J., Beglinger C., Stolte M., Wolff C., and Schulze J. 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-1623.
66. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman J., Korpela R., Poussa T., Tuure T., and Kuitunen M. 2006. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology 119: 192-198.
67. Langlands S.J., Hopkins M.J., Coleman N., and Cummings J.H. 2004. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53: 1610-1616.
68. Lawrence S., Korzenik J.R., and Mundy L.M. 2005. Probiotics for recurrent Clostridium diffi-cile disease. Medical Microbiology 54: 905-906.
69. Leduc M. 2002. Healing with probiotics. http://www.healingdaily.com/detoxificationdiet/probiotics. htm (Accessed November 23, 2007).
70. Lee Y.K., and Salminen S. 1995. The coming age of probiotics. Trends in Food Science and Technology 6: 241-245.
71. Lilley D.M., and Stillwell R.H. 1965. Probiotics: Growth promoting factors produced by microorganisms. Science 147: 747-748.
72. Macfarlane G.T., and Cummings J. 1999. Education and debate. British Medical Journal 318: 999-1003.
73. Macfarlane S. 2006. Review article: prebiotics in the gastrointestinal tract. Alimentary Pharmacology and Therapeutics 24: 701-714.
74. Mahida Y.R., and Rolfe Y.E. 2004. Host-bacterial interactions in inflammatory bowel disease. Clinical Science 107: 331-341.
75. Majamaa H., and Isolauri E. 1997. Probiotics: a novel approach in the management of food allergy. Journal of Allergy Clinical Immunology 99: 179-185.
76. Makarov K.S., and Koonin E.V. 2007. Evolutionary genomics of lactic acid bacteria. Journal of Bacteriology 189: 1199-1208.
77. Matsuzaki T., Hashimoto S., and Yokokura T. 1996. Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice. Medical Microbiology and Immunology 185: 157-161.
78. McFarland L.V. 2006. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology 101: 812-822.
79. Mechnikoff E. 1908. The Prolongation of Life. The English Translation, P. Chalmers Mitchell (ed.). G.P. Putnam's Sons, The Knickerbocker Press, New York and London, UK.
80. Meurman J.H., and Stamatova I. 2007. Probiotics: contributions to oral health. Oral Diseases 13: 443-451.
81. Midolo P.D., Lambert J.R., Hull R., Luo F., and Grayson M.L. 1995. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. Journal Applied Bacteriology 79: 475-479.
82. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot IC., Nicholls RJ., Gionchetti P., Campieri M., and Kamm M.A. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114.
83. Mitsuoka T. 1997. The Intestinal Flora and Its Important Relationship with Health. International Flora and Immunity: Intestinal Infection, Allergy, and Cancer. Special 20th Anniversary Edition of Healthiest. pp. 2-13. Published by Japan Yakult Honsa Co., Ltd.
84. Mussatto S.I., and Mancilha I.M. 2006. Non-digestible oligosaccharides: A review. Carbohydrate polymers 68: 587-597.
85. Nakajima Y., and Nishio K. 1993. Oligosaccharides: Production, properties and applications. Japanese Technology Reviews, Breach Science Publishers 3: 107-117.
86. Nemcova R., Bomba A., Gancarcikova S., Herich R., and Guba P. 1999. Study of the effect of Lactobacillus paracasei and fructooligosaccha rides on the faecal micro flora in weanling piglets. Berl M ü nch Tierärztl Wochenschr 112: 225-228.
87. Niers L.E.M., Hoekstra M.O., Timmerman H.M., van Uden N.O., de Graaf P.M.A., Smits H.H., Kimpen J.L.L., and Rijkers G.T. 2007. Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clinical and Experimental Immunology 149: 344-352.
88. Nikawa H. 2007. Application of probiotics in oral cavity. pp. 22-32. The 15th International Symposium on Lactic Acid Bacteria in Seoul, Korea. Lactic acid bacteria and oral health. (August 22, 2007).
89. O'Hara A.M., and Shanahan F. 2006. The gut floras-a forgotten organ. EMBO Report 688-693.
90. O'Mahony L., McCarthy l., Kelly P., Hurley G., Luo F., Chen K., O'Sullivan G.C., Kiely B., Collins J.K., Shanahan F., and Quigley E.M. 2005. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 541-551.
91. O'Sullivan M.G., Thornton G.M., O'Sullivan G.C., and Collins J.K. 1992. Probiotic bacteria: myth or reality. Trends in Food Science and Technology 31: 309-314.
92. Ouwehand A.C., Salminen S., and Isolauri E. 2002. Probiotics and overview of beneficial effects. Antonie van Leeuwenhoek 82: 279-289.
93. Ouwehand A., and Vesterlund S. 2003. Health aspects of probiotics. I Drugs 6: 573-580.
94. Park M.J., Kim J.S., Yim J.Y., Jung H.C., Song I. S., Lee J.J., Huh C.S., and Baek Y.J. 2001. The suppressive effect of a fermented milk containing Lactobacilli on Helicobacter pylori in Human Gastric Mucosa. Korean Journal Gastroenterology 38: 233-240.
95. Park J., and Floch M.H. 2007. Probiotics, prebiotics, and dietary fiber in gastrointestinal diseases. Gastroenterology Clinics of North America 36: 47-63.
96. Parker R.B. 1974. Probiotics, the other half of the antibiotic story. Animal Nutrition and Health 29: 4-8.
97. Parkes G.C. 2007. An overview of probiotics and prebiotics. Nursing Standard 21: 43-47.
98. Pinchuk I.V., Bressollier P., Verneuil B., Fenet B., Sorokulova I.B., Mégraud F., and Urdaci M.C. 2001. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrobial Agents Chemotherapy 45: 3156-3161.
99. Playne M.J. 1994. Production of carbohydrate-based functional foods using enzyme and fermentation technologies. Int Chem Eng Symp Ser 137: 147-156.
100. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., and Savilahti E. 2004. Lactobacillus GG effect increasing IFN-gamma production in infants with cow's milk allergy. Journal of Allergy Clinical Immunology 114: 131-136.
101. Promsopone B., Morishita T.Y., Aye P.P., Cobb C.W., Veldkamp A., and Clifford L.R. 1998. Evaluation of an avian-specific probiotic and Salmonella typhimurium-specific antibodies on the colonization of Salmonella typhimurium in broilers. Journal of Food Protection 61: 176-80.
102. Rasic J.L., and Kurmann J.A. 1978. Yoghurt. pp. 11-45. Published by the Authors. Dk-2720 Vanlose, Copenhagen, Denmark.
103. Reid G. 2003. The importance of guidelines in the development and application of probiotics. Current Pharm Des 11: 11-16.
104. Reid G. 2005a. Probiotics to prevent urinary tract infections: the rationale and evidence. World Journal of Urology 24: 28-32.
105. Reid G., and Bruce A.W. 2006. Probiotics to prevent urinary tract infections: the rationale and evidence. World Journal of Urology 24: 28-32.
106. Reid G., Charbonneau D., Erb L., Kochanowski B., Beuerman D., Poehner R., and Bruce A. 2005. Oral use of Lactobacillus rhamnosus GR-l and 1. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology 35: 131-134.
107. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., Roberfroid M., Rowland I., Cherbut C., and Klaenhammer T.R. 2003b. New scientific paradigms for probiotics and prebiotics. Journal of Clinical Gastroenterology 37: 105-118.
108. Ridlon J.M., Kang D.J., and Hylemon P.B. 2006. Bile salt biotransformations by human intestinal bacteria. Journal of Lipid Research 47: 241-259.
109. Roberfroid M.B. 1996. Functional effects of food components and the gastrointestinal system: chicory fructo-oligosaccharides. Nutrition Reviews 54: S38-S42.
110. Rubaltelli F.F., Biadaiolo R., Pecile P., and Nicoletti P. 1998. Intestinal flora in breast-and bottle-fed infants. Journal of Perinatal Medicine 26: 186-191.
111. Saavedra J.M. 2007. Use of probiotics in pediatrics, rationale, mechanisms of action, and practical aspects. Nutrition in Clinical Practice 22: 351-65.
112. Saier M., and Mansur H. 2005. Probiotics and prebiotics in human health. Journal of Molecular Microbiology and Biotechnology 10: 22-25.
113. Sako T., Matsumoto K., and Tanaka R. 1999. Recent progress on research and applications of non-digestible galacto-oligosaccharides. International Dairy Journal 9: 69-80.
114. Salminen S., Von Wright A.J., Morelli L., and Mateau P. 1998. Demonstration of safety of probiotics-A Review. International Journal of Food Microbiology 44: 93-106.
115. Salminen S., Von Wright A.J., Ouwehand, A.C., and Holzapfel W.H. 2001. Safety assessment of probiotics and starters, In: Fermentation and Food Safety. M.R. Adams and M.J.R. Nout (eds.), pp. 239-251. Aspen Publishers Inc., Gaithersburg, MD.
116. Saran S., Gopalan S., and Krishna TP. 2002. Use of fermented foods to combat stunting and failure to thrive. Nutrition 18: 393-396.
117. Shah N.P. 2007. Functional cultures and health benefits. International Dairy Journal 17: 1262-1277.
118. Shjortt C. 1999. The probiotic century: historical and current perspectives. Trends in Food Science and Technology 10: 411-417.
119. Shornikova A.V., Casas I., Mykkänen H., Salo E., and Vesikari T. 1997. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatric Infectious Disease Journal 16: 1103-1107.
120. Srivopoulou A., Papanikolaou E., Nikolaou C., Kokkini S., Lanaras S.T., and Arsenakis M. 1996. Antimicrobial and cytotoxic activities of Origanum essential oils. Journal of Agriculture and Food Chemistry 44: 1202-1205.
121. Su P., Henriksson A., and Mitchell H. 2007. Selected prebiotics support the growth of probiotic mono-cultures in vitro. Anaerobe 13: 134-9.
122. Szajewska H. 2007. Probiotics and prebiotics. in pediatrics: where are we now? Turkish Journal of Pediatrics 49: 231-44.
123. Tanaka R., and Sako T. 2002. Prebiotics: Type. Encyclopedia of Dairy Science. H. Roginski, J.W. Fuquay, and P.F. Fox (eds.), pp. 2256-2268. Elsevier Science Ltd., London and New York.
124. Tannock G.W. 1995. Role of probiotics. In: Human Colonic Bacteria: Role in Nutrition, Physiology, and Pathology, G.R. Gibson and G.T. Macfarlane (eds.), pp. 257-271. CRC Press, Boca Raton, FL.
125. Tannock G.W. 1998. Studies of the Intestinal microflora: A prerequisite for the development of probiotics. International Dairy Journal 8: 527-533.
126. Tannock G.W. 2002. Analysis of the intestinal microflora using molecular methods. European J. Clin. Nutrition 56 (SuppI)4: S44-9.
127. Tannock G.W. 2005. Probiotics and Prebiotics: Scientific Aspects, pp. 2-9. Cromwell Press: Norfolk, UK.
128. Tromm A., Niewerth U., Khoury M., Baestlein E., Wilhelms G., Schulze J., and Stolte M. 2004. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Journal of Gastroenterology 42: 365-369.
129. Vaalara O. 2003. Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy 33: 1634-1640.
130. Waldeck F. 1990. Funktionen des Magen-Darm-Kanals. R.F. Schmidt and G. Thews (eds.) Physiologie des Menschen (24.Aufl.), Springer Verlag, Berlin.
131. Walker W.A., and Duffy L.C. 1998, Diet and bacterial colonization: Role of probiotics and prebiotics. Journal of Nutritional Biochemistry 9: 668-677.
132. Xiao J.Z., Kondo S., Takahashi N., Miyaji K., Oshida K., Hiramatsu A., Iwatsuki K., Kokubo S., and Hoson A. 2003. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. Journal of Dairy Science 86: 2452-2461.
133. Yadva J.N.S., Gupta S., Varma I., and Tandon J.S. 1995. Neutralisation of enterotoxins of E.coli by coleonol (forskolin) in rabbit and guinea pig ileal loop models. Indian Journal of Animal Science 65: 1177-1181.
134. Zhang Q., Mousdicas N., Qiaofang Y., Al-Hassani M., Billings S. D., Susan M., Howard K.M., Ishii S., Shimiz T., and Travers J.B. 2005. Staphylococcal lipoteinhoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. Journal of Clinical investigation 115: 2855-2861.
135. Zoetendal E., and Mackie R.I. 2005. Chapter 1. Molecular Methods in Microbial Ecology. In: Probiotics and Prebiotics, Scientific Aspects, G. W. Tannock (ed.). Caister Academic Press, Norfolk, UK.